卵巢交界性肿瘤中淋巴结转移患者预后的临床分析

Clinical Analysis of Node Metastases in Borderline Ovarian Tumors

目的探讨卵巢交界性肿瘤中,淋巴结转移率和患者预后的关系。方法 40例卵巢交界性肿瘤患者实行了淋巴结清除术,其中27例行盆腔淋巴结清除术,4例行腹主动脉旁淋巴结清除术,9例同时行盆腔及腹主动脉淋巴结清除术。2例患者因合并有宫颈癌行淋巴结清除术,另有6例患者术中发现淋巴结增大行淋巴结清除术。结果 6例患者淋巴结病理改变与卵巢交界性肿瘤有关,9例患者淋巴结呈输卵管子宫内膜异位样改变。淋巴结转移者均为浆液性交界性肿瘤合并有腹膜种植,黏液性交界性肿瘤和临床期别早的患者未见淋巴结转移。该研究中的所有卵巢交界性肿瘤患者没有直接死于该肿瘤。结论卵巢交界性肿瘤预后也非常好,当患者为浆液性交界性肿瘤伴有淋巴结增大时应行淋巴结清除术。

Objective To explore the relationship of the node metastases and prognosis in borderline ovarian tumors （BOT）. Method Lymphadenectomy were carried out in 40 cases of BOT （27 pelvic lymphadenectomy ,4 paraaortic lymphadenectomy and 9 both procedures）. Two cases was because of associated cancer （uterine cervix） and six cases was because of bulky nodes were discovered during the surgical procedure. Results Six patients＇ nodes pathological reaction chanpe was related to the BOT and endosalpingiosis was seen in nine cases. All cases with node metastases had serous BOT with peritoneal implants. None of the patients with mucinous tumors and early-stage tumor had nodal involvement. None of the patients with BOT died of it in this study . Conclusion The prognosis of BOT patients is pretty well. Lymphadenectomy should be carried out when the case is serous BOT with bullky nodes.